Curt LaBelle
President chez Global Health Investment Fund
Fortune : 1 M $ au 31/03/2024
Profil
Curt H.
LaBelle currently holds multiple director positions at Serum Institute of India Pvt Ltd., Vedanta Biosciences, Inc., KeepYourSight.
Foundation, Ophirex, Inc., Revelation Biosciences Sub, Inc., CXL Ophthalmics LLC, Atticus Medical Pty Ltd., AXA Investment Managers (Paris) SA (Investment Management), Global Health Investment Fund, IanTech, Inc., Adjuvant Capital LP, and Maternal Newborn Health Innovations Corp.
He previously held chairman positions at NuVasive Clinical Services Monitoring, Inc., SafeOp Surgical, Inc., Exagen, Inc., and Alydia Health, Inc. He also held director positions at KAI Pharmaceuticals, Inc., Vidacare Corp., Coherex Medical, Inc., Tullis Health Investors, Inc., Endoscopic Technologies, Inc., TransMolecular, Inc., Sirion Therapeutics, Inc., Atomo Diagnostics Ltd., Eyenovia, Inc., and Revelation Biosciences, Inc. Additionally, he was a managing director at Global Health Investment Advisors LLC and a venture partner at Adjuvant Capital LP.
LaBelle received an MBA and a doctorate from The Trustees of Columbia University in The City of New York and an MBA from Columbia Business School.
He also received an undergraduate degree from Brigham Young University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATOMO DIAGNOSTICS LTD.
10,18% | 19/12/2023 | 65 051 280 ( 10,18% ) | 1 M $ | 31/03/2024 |
Postes actifs de Curt LaBelle
| Sociétés | Poste | Début |
|---|---|---|
KeepYourSight Foundation
 KeepYourSight Foundation Investment Trusts/Mutual FundsMiscellaneous KeepYourSight Foundation provides e-health initiative in the fight against blindness. The company is headquartered in united States. | Director/Board Member | - |
Revelation Biosciences Sub, Inc.
 Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Part of Revelation Biosciences, Inc., Revelation Biosciences Sub, Inc. develops medical devices. The private company is based in San Diego, CA. James M. Rolke has been the CEO of the company since 2020. Revelation Biosciences Sub was acquired by Petra Acquisition, Inc. on January 11, 2022 for $87.36 million. | Director/Board Member | 01/01/2021 |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Private Equity Investor | - |
| Atticus Medical Pty Ltd. | Director/Board Member | 01/09/2015 |
Ophirex, Inc.
 Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Director/Board Member | - |
IanTech, Inc.
 IanTech, Inc. Medical SpecialtiesHealth Technology IanTech, Inc. develops ophthalmic devices for cataract surgery. Its products include miLoop, miPhaco, miMissions, and miResources. The company was founded by Luke Clauson and Sean Ianchulev and is headquartered in Reno, NV. | Private Equity Investor | 01/06/2015 |
Serum Institute of India Pvt Ltd.
 Serum Institute of India Pvt Ltd. BiotechnologyHealth Technology Serum Institute of India Pvt Ltd. engages in the production and exportation of anti-cancer products and viral vaccines. Its products include bacterial vaccines, recombinant and combination vaccines, viral vaccines, influenza vaccines. uro-oncology, and polysaccharide conjugate vaccine. The company was founded by Cyrus S. Poonawalla in 1966 and is headquartered in Pune, India. | Private Equity Investor | 01/06/2017 |
Maternal Newborn Health Innovations Corp.
 Maternal Newborn Health Innovations Corp. Medical/Nursing ServicesHealth Services Maternal Newborn Health Innovations Corp. is a company based in Kinnelon, NJ. Gary M. Cohen has been the CEOs since incorporation. Maternal Newborn Health Innovations Corp. was founded by Gary M. Cohen. | Director/Board Member | 01/07/2022 |
CXL Ophthalmics LLC
 CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services CXL Ophthalmics LLC develops a treatment for eyecare. The company is based in Encinitas, CA. The CEO of the company is Michael D. Webb. | Director/Board Member | 01/10/2022 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Curt LaBelle
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Curt LaBelle
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Brigham Young University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| EXAGEN INC. | Health Services |
| ATOMO DIAGNOSTICS LIMITED | Health Technology |
| EYENOVIA, INC. | Health Technology |
| REVELATION BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 25 |
|---|---|
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Vidacare Corp.
 Vidacare Corp. Medical SpecialtiesHealth Technology Vidacare Corp. develops, manufactures, and markets intraosseous access devices for vascular access and bone biopsies. The company was founded by Eric Eisbrenner, Jim Thomsen, and Larry Miller on March 29, 2002 and is headquartered in San Antonio, TX. | Health Technology |
Coherex Medical, Inc.
 Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | Health Technology |
NuVasive Clinical Services Monitoring, Inc.
 NuVasive Clinical Services Monitoring, Inc. Medical/Nursing ServicesHealth Services NuVasive Clinical Services Monitoring, Inc. provides onsite and web-based monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. It facilitates the surgical process and reduces surgical risk by providing critical information and alerts to surgeons of potential harm or compromise to the spinal cord or neural structures. The company was founded by Roger Conley in 2000 and is headquartered in San Diego, CA. | Health Services |
SafeOp Surgical, Inc.
 SafeOp Surgical, Inc. Medical SpecialtiesHealth Technology SafeOp Surgical, Inc. operates as a medical device company. It offers portable neuro monitoring devices that enable the detection of nerve damage, such as positioning effect, an injury to peripheral nerves related to patient positioning during surgery or prolonged sedation. The company was founded in 2011 and is headquartered in Hunt Valley, MD. | Health Technology |
| Investor Growth Capital LLC | |
Tullis Health Investors, Inc.
 Tullis Health Investors, Inc. Investment ManagersFinance Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida. | Finance |
Endoscopic Technologies, Inc.
 Endoscopic Technologies, Inc. Medical SpecialtiesHealth Technology Endoscopic Technologies, Inc. manufactured and distributed medical devices. Its product lines span three cardiac surgery disciplines including surgical radio frequency ablation, valve replacement or repair, and coronary artery bypass grafting. The company was founded in 1996 and was headquartered in San Ramon, CA. | Health Technology |
TransMolecular, Inc.
 TransMolecular, Inc. BiotechnologyHealth Technology TransMolecular is an oncology-focused biotechnology company committed to developing novel proprietary drugs to diagnose and treat human diseases using a novel tumor targeting platform called TM601. Their development program to date has explored the therapeutic use of TM601 in cancer and neovascular diseases of the eye, and their lead candidate, TM601 conjugated to the radioactive isotope 131I, has a Special Protocol Agreement (SPA) with the FDA for a pivotal, Phase 3 trial in newly diagnosed glioblastoma multiforme (glioma). TM601 has unique properties of highly specific tumor cell binding and internalization while not affecting normal cells, targeting both primary disease sites and metastases. The interaction of TM601 with a specific protein known to be over-expressed on the surface of tumor cells and vascular endothelium is implicated in these tumor-specific binding properties. Conjugated to an anti-cancer radioactive isotope, TM601 has been successful in human and animal models in demonstrating selective targeting and uptake in a number of different tumor types, and in tumor locations within the central nervous system (CNS) and peripherally. Expanded research confirms that TM601 can deliver a variety of conjugates, creating potential for development of a wide array of anti-cancer therapies. In addition to the tumor targeting capability of TM601, a number of studies have also revealed that TM0601 exerts robust anti-angiogenic effects on vessels associated with neovascular disease. Pursuing this anti-angiogenic potential further, They have also determined the utility of TM601 in animal ophthalmic models. The company is leveraging its platform in strategic collaborations with partners seeking to expand product pipelines, extend product life-cycles for existing anti-tumor compounds, or optimize therapeutic activity of marginally effective or restrictively toxic drugs. | Health Technology |
Sirion Therapeutics, Inc.
 Sirion Therapeutics, Inc. BiotechnologyHealth Technology Sirion Therapeutics, Inc. provides biopharmaceutical products and services. It manufactures, develops and commercialize ophthalmic products for eye diseases. The company was founded by Barry Butler, Susan Benton, Philippe Boulangeat and Roger Vogel in November 2005 and is headquartered in Tampa, FL. | Health Technology |
Serum Institute of India Pvt Ltd.
Serum Institute of India Pvt Ltd. BiotechnologyHealth Technology Serum Institute of India Pvt Ltd. engages in the production and exportation of anti-cancer products and viral vaccines. Its products include bacterial vaccines, recombinant and combination vaccines, viral vaccines, influenza vaccines. uro-oncology, and polysaccharide conjugate vaccine. The company was founded by Cyrus S. Poonawalla in 1966 and is headquartered in Pune, India. | Health Technology |
AXA Investment Managers (Paris) SA (Investment Management)
 AXA Investment Managers (Paris) SA (Investment Management) Investment ManagersFinance AXA Investment Managers (Paris) SA (Investment Management) (AXA IM) is the structured finance division of AXA Investment Managers (Paris) SA, itself a subsidiary of AXA SA (XP: CS) in France. Created in 2000, the firm is a dedicated buy-side platform which is organized into investment teams specializing in managing structured finance products including corporate credit, structured credit invest, asset backed securities and insurance linked securities for a range of clients including pension funds, corporations, governments, institutions and insurance companies. Their Responsible Investment team utilizes AXA Investment Managers' multi-expert model and RI Search© to conducts ESG research that informs investment decision-making and active stewardship practices. | Finance |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Health Technology |
Patricia Industries AB
 Patricia Industries AB Investment ManagersFinance Patricia Industries AB (Patricia Industries) is a private equity subsidiary of Investor AB founded in 1972. The firm is headquartered in Stockholm, Sweden. | Finance |
Global Health Investment Fund
 Global Health Investment Fund Investment ManagersFinance Global Health Investment Fund seeks investment opportunities in global health technologies. The fund invests in new drugs & vaccines, emerging diagnostic tools, child-friendly formulations of existing products, expanding manufacturing capacity and other applications. It provides financing in the form of mezzanine for later-stage capital requirements. | Finance |
Global Health Investment Advisors LLC
 Global Health Investment Advisors LLC Investment ManagersFinance Global Health Investment Advisors LLC operates as an alternative investment manager. The company was founded in 2015 and is headquartered in New York, NY. | Finance |
IanTech, Inc.
IanTech, Inc. Medical SpecialtiesHealth Technology IanTech, Inc. develops ophthalmic devices for cataract surgery. Its products include miLoop, miPhaco, miMissions, and miResources. The company was founded by Luke Clauson and Sean Ianchulev and is headquartered in Reno, NV. | Health Technology |
Alydia Health, Inc.
 Alydia Health, Inc. Medical SpecialtiesHealth Technology Alydia Health, Inc. operates as medical device company which provides solution to postpartum hemorrhage. The company was founded by Nathan Bair and Jessie Becke on May 8, 2018 and is headquartered in Menlo Park, CA. | Health Technology |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Commercial Services |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Finance |
Revelation Biosciences Sub, Inc.
Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Part of Revelation Biosciences, Inc., Revelation Biosciences Sub, Inc. develops medical devices. The private company is based in San Diego, CA. James M. Rolke has been the CEO of the company since 2020. Revelation Biosciences Sub was acquired by Petra Acquisition, Inc. on January 11, 2022 for $87.36 million. | Health Technology |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services CXL Ophthalmics LLC develops a treatment for eyecare. The company is based in Encinitas, CA. The CEO of the company is Michael D. Webb. | Health Services |
| Atticus Medical Pty Ltd. | |
Maternal Newborn Health Innovations Corp.
Maternal Newborn Health Innovations Corp. Medical/Nursing ServicesHealth Services Maternal Newborn Health Innovations Corp. is a company based in Kinnelon, NJ. Gary M. Cohen has been the CEOs since incorporation. Maternal Newborn Health Innovations Corp. was founded by Gary M. Cohen. | Health Services |
KeepYourSight Foundation
KeepYourSight Foundation Investment Trusts/Mutual FundsMiscellaneous KeepYourSight Foundation provides e-health initiative in the fight against blindness. The company is headquartered in united States. | Miscellaneous |
